Clinical Trials
181 trialsA Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Boehringer Ingelheim
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
ModernaTX, Inc.
VICTORIE
Pfizer
GLORIOSA
AbbVie
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Alterome Therapeutics, Inc.
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
GlaxoSmithKline
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
Eli Lilly and Company
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
Hoffmann-La Roche
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
MedImmune LLC
FOREFRONT
AstraZeneca
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
SaLuDo
PharmaMar
LADOGA
AstraZeneca
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
Amgen
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
BioNTech SE
PATHFINDER 2: A Multi-Cancer Early Detection Study
GRAIL, Inc.
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
AbbVie
SABRE
Boston Scientific Corporation
OPAL
Janssen Biotech, Inc.
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
Janssen Research & Development, LLC
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Sanofi
PALOMA
Janssen Research & Development, LLC
Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors
AbbVie
A Study of ZW191 in Participants With Solid Tumors
Zymeworks BC Inc.
Spotlight
Astellas Pharma Inc
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
AbbVie
Study of LP-184 in Patients With Advanced Solid Tumors
Lantern Pharma Inc.
Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors
EMD Serono
PROVIDENCE
AbbVie
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
Endocyte
IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor
Immatics Biotechnologies GmbH
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
Nectin Therapeutics Ltd
ROWAN
Boston Scientific Corporation
ELEPHAS-02
Elephas
VOYAGER
Boston Scientific Corporation
IMbrella B
Hoffmann-La Roche
Real World Registry for Use of the Ion Endoluminal System
Intuitive Surgical
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
GlaxoSmithKline
ARTACUS
Replimune, Inc.
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
Intra-IMMUSG Pte Ltd
Durvalumab and Tremelimumab for Pediatric Malignancies
AstraZeneca
SERENA-6
AstraZeneca
Extended Access of Momelotinib in Adults With Myelofibrosis
GlaxoSmithKline
GLOW
Astellas Pharma Inc
IGNYTE-ESO
USWM, LLC (dba US WorldMeds)
LIBRETTO-001
Eli Lilly and Company
ROSY-O
AstraZeneca
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Bayer
DeLLphi-307
Amgen
NHS-Galleri
GRAIL, Inc.